ArticleJournal of the American Heart Association2026
Association Between Stress Hyperglycemia Ratio and Death in Patients With Moderate to Severe Tricuspid Regurgitation.
Article in Journal of the American Heart Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTricuspid regurgitation (TR) progression correlates with worsened clinical outcomes. The stress hyperglycemia ratio (SHR), a biomarker of acute glycemic dysregulation under stress, has prognostic validity in multiple valvular diseases. This study aims to investigate the correlation between SHR and clinical prognosis in patients with moderate to severe TR.
methodsLeveraging the RED-CARPET (Real-World Data of Cardiometabolic Protection) registry from the First Affiliated Hospital of Sun Yat-sen University, we analyzed 531 patients with moderate-to-severe TR categorized into quartiles (quartiles 1-4) by SHR. Primary end points were all-cause and cardiovascular disease (CVD) death. The association between SHR and death was assessed using a multivariable-adjusted Cox regression model. The incremental predictive value of incorporating SHR into the traditional risk model was also analyzed.
resultsThe cohort (mean age, 70.93 years) exhibited 38.9% all-cause deaths (207 events) and 20.0% CVD deaths (106 events) over 5.9-year median follow-up. After full adjustment, patients with SHR quartile 4 carried a 108% excess risk of all-cause death (hazard ratio [HR], 2.08 [95% CI, 1.34-3.23]) and more than twice the hazard of CVD death (HR, 2.40 [95% CI, 1.30-4.43]) versus quartile 1. The addition of SHR into the basic risk model for all-cause and CVD death improved the concordance statistics (both
conclusionsElevated SHR is associated with an increased risk of all-cause death and CVD death in patients with moderate to severe TR.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.